Exploring the Impact of SARS-CoV-2 Infection on the Central Nervous System
With a global effort underway to find prophylactic and therapeutic options to combat the COVID-19 pandemic, more information is becoming available on the pathogenesis of SARS-CoV-2 and the associated immune response. However, significant gaps remain in our understanding of the impact of SARS-CoV-2 on the central nervous system. In this webinar, part of our Infectious Disease Webinar Series, Eric Song will highlight advances in this field and discuss the neuro-invasive potential and neuroinflammatory implications of SARS-CoV-2 infection.
Related Multimedia
-
How EasySep™ Magnetic Cell Separation Technology Works: Fast and Easy Cell Isolation
Publish Date: April 20, 2016 -
STEMCELL Journal Club: Cerebral Organoids for Human-Specific Infection Modeling
Publish Date: May 25, 2020
Explore Our Products
-
STEMdiff™ SMADi Neural Induction Kit
Serum-free medium kit for highly efficient SMAD inhibition-mediated neural induction of human ES and iPS cells -
SARS-CoV-2 Recombinant Nucleocapsid Protein, aa1-419 (E. coli-expressed)
Novel coronavirus (SARS-CoV-2/ 2019-nCoV) nucleocapsid protein (recombinant), amino acids Met1-Ala419, His & T7 tags -
SARS-CoV-2 Recombinant Spike Protein, aa16-685 (HEK293-expressed)
SARS-CoV-2 recombinant spike protein, amino acids Val16-Arg685, FLAG & His tags -
SARS-CoV-2 Recombinant Spike Protein, aa319-541 (Yeast-expressed)
SARS-CoV-2 recombinant spike protein, amino acids Arg319-Phe541, His tag